Тезепелумаб Астразенека

Amgen, AstraZeneca's tezepelumab is looking for...

Two key AstraZeneca medicines accepted for use ...

(PDF) [Tezepelumab: a new option for the treatm...

What is Tezepelumab? Side Effects, Benefits, an...

Japan Archives - Clinical Trials Arena

AstraZeneca shares tumble 15% on big drug trial...

Relief for AZ, Amgen as FDA okays severe asthma...

US FDA grants priority review to tezepelumab to...

AstraZeneca Welcomes Neurofibromatosis And Asth...

Tezepelumab Could Help Amgen Develop Its Inflam...

TEZSPIRE® (tezepelumab-ekko) HCP on LinkedIn: D...

AstraZeneca buys US lung drug firm Pearl Therap...

Amgen, AstraZeneca's tezepelumab hits goal in a...

(PDF) Tezepelumab as an Emerging Therapeutic Op...

Tezepelumab Shows Potential for COPD, Negative ...

Long-term safety and efficacy of tezepelumab in...

Tezepelumab Effective in Severe Asthma Cohorts ...

AstraZeneca severe asthma treatment Tezspire ge...

Is Tezepelumab approved by the FDA?

US FDA approves Amgen-AstraZeneca’s Tezspire fo...

By IPP Bureau | September 10, 2024

Tezspire (tezepelumab) approved in the European...

Купить Тецентрик (Атезолизумаб) - Tecentriq (At...

FDA grants priority review to BLA for AstraZene...

By IPP Bureau | June 22, 2024

AstraZeneca Truqap plus Faslodex recommended fo...

Tezepelumab Benefits Asthma Patients Year-Round...

FDA Approves Tezepelumab for Self-Administratio...

Figure 2 from Efficacy and Potential Positionin...

ДЭМБ “Астразенека” компанийн вакцинаар дархлааж...

Tezepelumab Regulatory Submission Accepted and ...

Tezepelumab in patients with allergic and eosin...

АстраЗенека вакцины хоёр дахь тунг энэ сарын 15...

AstraZeneca (AZN) Investor Presentation - Slide...

AstraZeneca to acquire TeneoTwo and its clinica...